Milestone Pharmaceuticals Inc.
For the period ended Jun 16, 2025. Filed Jun 16, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jun 16, 2025 · Filed Jun 16, 2025
Use the contents to explore the available documents and sections.
MIST$0.76+10.2%Stored close · as of Nov 6, 2026
Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MILESTONE PHARMACEUTICALS INC. | ||
| Dated: June 16, 2025 | By: | /s/Amit Hasija |
|---|---|---|
| Amit Hasija | ||
| Chief Financial Officer | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.